
Walgreens (WBA) Stock Forecast & Price Target
Walgreens (WBA) Analyst Ratings
Bulls say
Walgreens Boots Alliance operates over 8,000 retail pharmacy locations across the U.S., serving nearly three-quarters of Americans within a five-mile radius, generating approximately two-thirds of its revenue from prescription drug sales. The company's diverse revenue streams, including retail products and healthcare services, position it as a comprehensive healthcare provider while enhancing its omnichannel experience through initiatives like Health Corner and Village Medical. Additionally, ongoing investments in services, a focus on improving free cash flow, and strategic debt management signal a strong potential for long-term growth in a rapidly evolving retail and healthcare landscape.
Bears say
Walgreens Boots Alliance faces significant downside risks, including increased pricing pressure and a deteriorating retail environment, which could adversely affect its revenue streams. The company is experiencing weak cash flow and slower growth in the U.S., prompting management to suspend its quarterly cash dividend as part of a strategic capital allocation adjustment. These factors contribute to an overall negative outlook for the stock, highlighting concerns over its financial stability and future performance.
This aggregate rating is based on analysts' research of Walgreens and is not a guaranteed prediction by Public.com or investment advice.
Walgreens (WBA) Analyst Forecast & Price Prediction
Start investing in Walgreens (WBA)
Order type
Buy in
Order amount
Est. shares
0 shares